National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 9) (PB 88 of 2016) (Cth)

PB 88 of 2016

National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 9)

National Health Act 1953

I, ANDREW RINTOUL, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated       28  September 2016

ANDREW RINTOUL

Assistant Secretary (Acting)

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 9).

(2)   This Determination may also be cited as PB 88 of 2016.

1. Commencement

This Determination commences on 1 October 2016.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Iloprost

Omit

Imatinib

[2]     Schedule 1, after item dealing with Mefanamic acid

Omit

Megestrol

[3]     Schedule 2, after item dealing with Idarubicin

Insert

Imatinib